US Stock MarketDetailed Quotes

NTLA Intellia Therapeutics

Watchlist
  • 24.630
  • +1.480+6.39%
Close Jul 11 16:00 ET
  • 25.240
  • +0.610+2.48%
Pre 08:04 ET
2.38BMarket Cap-4586P/E (TTM)

Intellia Therapeutics Stock Analyst Ratings & Price Target

Analyst Rating

Updated: Jul 11, 2024

Based on 19 analysts giving stock ratings to Intellia Therapeutics in the past 3 months

Strong Buy

  • Buy

    78.95%
  • Hold

    21.05%
  • Sell

    0.00%

Price Target

Updated: Jul 11, 2024

The average Intellia Therapeutics stock price target is 59.73 with a max estimate of 95.00 and a min estimate of 24.00

Detailed RatingsDetailed RatingsDetailed Ratings

Detailed Ratings

Receive timely notifications of rating changes

View more detailed ratings of institutions and analysts

View rating details page for historical data

Download APP

Analyst Ratings Disclaimer

Analysis

Analyst Rating

Updated: Jul 11, 2024

Strong Buy

  • Buy

    78.95%
  • Hold

    21.05%
  • Sell

    0.00%

Price Target

Updated: Jul 11, 2024

Heat List
US
Overall
Symbol
Latest Price
%Chg